- The FDA approves Pfizer's (PFE) Duavee for the treatment of moderate-to-severe hot flashes and for the prevention of post-menopausal osteoporosis.
- PFE partner Ligand Pharmaceuticals (LGND) got a big boost from the news Thursday, rising 7%.
- Notably, the drug is a selective estrogen receptor modulator combined with conjugated estrogens. Premarin is a conjugated estrogen tablet and made the news earlier this week after new research suggested there may be a link between the drug and the risk of blood clots.
- Another FDA-approved post-menopausal osteoporosis drug is Eli Lilly's (LLY) Evista.
at Zacks.com (Nov 18, 2014)